Hemolysis after subcutaneous deoxycholic acid overdose - 13/01/22
Doi : 10.1016/j.ajem.2021.08.021
Abigail Sharpe, PharmD a, ⁎ 
, Mary O'Keefe, PharmD a, Katie Windsor b, Jillian Theobald, MD, PhD a, Ryan Feldman, PharmD a
, Mary O'Keefe, PharmD a, Katie Windsor b, Jillian Theobald, MD, PhD a, Ryan Feldman, PharmD a a Wisconsin Poison Control Center, 999 N 92nd Street, Suite 600, Wauwatosa, WI 53226, United States of America
b Concordia University Wisconsin School of Pharmacy; 12800 N Lake Shore Drive, Mequon, WI, 53097, United States of America
⁎Corresponding author.
Abstract |
This report describes a case of hemolysis in a patient injecting deoxycholic acid and benzyl alcohol for aesthetic benefit without medical supervision. The concentration and dose injected by the patient resulted in a 10-fold overdose of deoxycholic acid in comparison to the FDA-recommended dosing for the approved indication. Providers should be aware of medically unsupervised use of DCA and other injectables and the potential risks associated with this practice.
Le texte complet de cet article est disponible en PDF.Keywords : Deoxycholic acid, Hemolysis, Overdose
Plan
© 2021
Elsevier Inc. Tous droits réservés.
Vol 52
P. 268.e1-268.e2 - février 2022 Retour au numéro
Article précédent
- Wide complex tachycardia in dialysis patients is not always hyperkalemia
- Kenny Hoang, Philip Pazderka, Wael Hakmeh
- Ultrasound-guided spinal accessory nerve block for intractable trapezius pain
- Meghan Kelly Herbst, Ryan Sorkin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?